About Us

At ImmuneID, we transform precision immunology by combining our proprietary ImmuneID platform together with advanced bioinformatic analysis and deep knowledge of immune system biology. We are passionate, love tough problems and never shy away from new challenges. We believe in a culture of integrity, transparency, communication, and accountability. We trust our staff to perform to the best of their abilities. Above all, we are a team motivated by patient success.

Our Team

James S. Scibetta

CEO

Annalisa D’Andrea, PhD

President and CSO

Jeremiah Degenhardt, PhD

Senior Vice President, Computational Biology

Alexandra Joseph, PhD
Vice President, Research

Sulynn Barnes

Senior Director, Head of People & Operations

Our Board of Directors

Christoph Westphal,
MD, PhD

Chair, ImmuneID BOD
Partner, Longwood Fund

Ittai Harel

ImmuneID BOD
Managing Partner, Pitango Healthtech Fund

Peter Hutt

ImmuneID BOD
Senior Counsel, Covington & Burling LLP

Dan Janney

ImmuneID BOD
Managing Partner, Alta Partners

Steve Kafka, PhD

ImmuneID BOD
Managing Partner, Section 32

James S. Scibetta

ImmuneID, CEO and Director

Pam Stetkiewicz, PhD
Chief Operating Officer Arbor Biotechnologies

Our Founders and Advisors

Steve Elledge, PhD​

Co-founder, ImmuneID

Tomasz Kula, PhD

Co-founder, ImmuneID

H. Benjamin Larman, PhD

Co-founder, ImmuneID

Michael Mina, MD PhD

SAB, ImmuneID

David Walt PhD

Advisor, ImmuneID

Investors